Data from Investigational Device Exemption (IDE) study in Roux-en-Y gastric bypass procedures used to support application for De Novo classification Second IDE approved for U.S. clinical trial for ...
Johnson & Johnson gave some clarity on when it would be filing for submission for the Ottava surgical robotics platform during a recent earnings call. The New Brunswick, NJ-based company said it would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results